New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk

BACKGROUND: The use of estrogen plus progestin therapy increases both breast cancer incidence and breast tenderness. Whether breast tenderness during estrogen plus progestin therapy is associated with breast cancer risk is uncertain. METHODS: We analyzed data from the Women’s Health Initiative Estro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Crandall, Carolyn J., Aragaki, Aaron K., Chlebowski, Rowan T., McTiernan, Anne, Anderson, Garnet, Hendrix, Susan L., Cochrane, Barbara B., Langer, Robert D., Kuller, Lewis H., Cauley, Jane A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670683/
https://ncbi.nlm.nih.gov/pubmed/19822825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archinternmed.2009.303
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados